Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation
暂无分享,去创建一个
Jason T. Stevens | D. Baker | D. Eisenberg | Stuart A. Sievers | J. Karanicolas | Lin Jiang | Howard W. Chang | A. Zhao | O. Zirafi | J. Münch | D. Baker | D. Baker
[1] K. Bailey,et al. The X-ray interpretation of denaturation and the structure of the seed globulins. , 1935, The Biochemical journal.
[2] F. Studier,et al. Use of T7 RNA polymerase to direct expression of cloned genes. , 1990, Methods in enzymology.
[3] A. Garrett,et al. Ockham’s Razor , 1991 .
[4] E. Mandelkow,et al. The switch of tau protein to an Alzheimer‐like state includes the phosphorylation of two serine‐proline motifs upstream of the microtubule binding region. , 1992, The EMBO journal.
[5] G. Drewes,et al. Alzheimer-like paired helical filaments and antiparallel dimers formed from microtubule-associated protein tau in vitro , 1992, The Journal of cell biology.
[6] Collaborative Computational,et al. The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.
[7] E. Mandelkow,et al. Structural studies of tau protein and Alzheimer paired helical filaments show no evidence for beta-structure. , 1994, The Journal of biological chemistry.
[8] H. Wolfson,et al. Shape complementarity at protein–protein interfaces , 1994, Biopolymers.
[9] E. Mandelkow,et al. Oxidation of cysteine-322 in the repeat domain of microtubule-associated protein tau controls the in vitro assembly of paired helical filaments. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[10] C. Soto,et al. Inhibition of Alzheimer's amyloidosis by peptides that prevent beta-sheet conformation. , 1996, Biochemical and biophysical research communications.
[11] J. Ávila,et al. Polymerization of tau into filaments in the presence of heparin: the minimal sequence required for tau-tau interaction. , 1996, Journal of neurochemistry.
[12] L. Tjernberg,et al. Arrest of -Amyloid Fibril Formation by a Pentapeptide Ligand (*) , 1996, The Journal of Biological Chemistry.
[13] J. Ávila,et al. Polymerization of τ into Filaments in the Presence of Heparin: The Minimal Sequence Required for τ ‐ τ Interaction , 1996 .
[14] G. Murshudov,et al. Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.
[15] E. Mandelkow,et al. A nucleated assembly mechanism of Alzheimer paired helical filaments. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[16] E. Mandelkow,et al. Rapid assembly of Alzheimer-like paired helical filaments from microtubule-associated protein tau monitored by fluorescence in solution. , 1998, Biochemistry.
[17] B. Chesebro,et al. Effects of CCR5 and CD4 Cell Surface Concentrations on Infections by Macrophagetropic Isolates of Human Immunodeficiency Virus Type 1 , 1998, Journal of Virology.
[18] Klaus Schmidt,et al. Labelling of peptides with 1.4-nm gold particles to demonstrate their binding sites in the rat spinal cord , 1999, Journal of Neuroscience Methods.
[19] E. Mandelkow,et al. Assembly of t protein into Alzheimer paired helical filaments depends on a local sequence motif ( 306 VQIVYK 311 ) forming b structure , 2000 .
[20] H. M. Petrassi,et al. Structure-Based Design of N-Phenyl Phenoxazine Transthyretin Amyloid Fibril Inhibitors , 2000 .
[21] E. Mandelkow,et al. Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[22] D. Selkoe. Alzheimer's disease: genes, proteins, and therapy. , 2001, Physiological reviews.
[23] M. Findeis,et al. Peptide inhibitors of beta amyloid aggregation. , 2002, Current topics in medicinal chemistry.
[24] F. Kirchhoff,et al. Nef Enhances Human Immunodeficiency Virus Type 1 Infectivity and Replication Independently of Viral Coreceptor Tropism , 2002, Journal of Virology.
[25] D. Baker,et al. Design of a Novel Globular Protein Fold with Atomic-Level Accuracy , 2003, Science.
[26] Bettina Schmitt,et al. Selection of D‐Amino‐Acid Peptides That Bind to Alzheimer's Disease Amyloid Peptide Aβ1–42 by Mirror Image Phage Display , 2003, Chembiochem : a European journal of chemical biology.
[27] Kevin Cowtan,et al. research papers Acta Crystallographica Section D Biological , 2005 .
[28] D. Kirschner,et al. The Formation of Straight and Twisted Filaments from Short Tau Peptides* , 2004, Journal of Biological Chemistry.
[29] D. Baker,et al. Computational redesign of protein-protein interaction specificity , 2004, Nature Structural &Molecular Biology.
[30] B. Reif,et al. Structure and orientation of peptide inhibitors bound to beta-amyloid fibrils. , 2005, Journal of molecular biology.
[31] C. Dobson,et al. Amyloid fibril formation can proceed from different conformations of a partially unfolded protein. , 2005, Biophysical journal.
[32] E. Mandelkow,et al. Purification of recombinant tau protein and preparation of Alzheimer-paired helical filaments in vitro. , 2005, Methods in molecular biology.
[33] Robert A. Grothe,et al. Structure of the cross-β spine of amyloid-like fibrils , 2005, Nature.
[34] A. Doig,et al. N-Methylated peptide inhibitors of beta-amyloid aggregation and toxicity. Optimization of the inhibitor structure. , 2006, Biochemistry.
[35] K. Sciarretta,et al. Peptide-based inhibitors of amyloid assembly. , 2006, Methods in enzymology.
[36] D. Baker,et al. The 3D profile method for identifying fibril-forming segments of proteins. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[37] Barry M Wise,et al. Prediction of nucleating sequences from amyloidogenic propensities of tau-related peptides. , 2006, Biochemistry.
[38] S. Constantinescu,et al. Inhibitors of amyloid toxicity based on beta-sheet packing of Abeta40 and Abeta42. , 2006, Biochemistry.
[39] C. Masters,et al. A primer of amyloid nomenclature , 2007, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[40] A. Doig,et al. N-methylated peptide inhibitors of β-amyloid aggregation and toxicity , 2007 .
[41] F. Kirchhoff,et al. Semen-Derived Amyloid Fibrils Drastically Enhance HIV Infection , 2007, Cell.
[42] Heather T. McFarlane,et al. Atomic structures of amyloid cross-β spines reveal varied steric zippers , 2007, Nature.
[43] Atanas V Koulov,et al. Functional amyloid--from bacteria to humans. , 2007, Trends in biochemical sciences.
[44] Boris Schmidt,et al. Screening for inhibitors of tau protein aggregation into Alzheimer paired helical filaments: a ligand based approach results in successful scaffold hopping. , 2007, Current Alzheimer research.
[45] Randy J. Read,et al. Phaser crystallographic software , 2007, Journal of applied crystallography.
[46] W. Greene,et al. The Cationic Properties of SEVI Underlie Its Ability To Enhance Human Immunodeficiency Virus Infection , 2008, Journal of Virology.
[47] J. Agar,et al. Fitting neurological protein aggregation kinetic data via a 2-step, minimal/"Ockham's razor" model: the Finke-Watzky mechanism of nucleation followed by autocatalytic surface growth. , 2008, Biochemistry.
[48] David Eisenberg,et al. Molecular mechanisms for protein-encoded inheritance , 2009, Nature Structural &Molecular Biology.
[49] David Eisenberg,et al. In Brief , 2009, Nature Reviews Neuroscience.
[50] David Eisenberg,et al. Identifying the amylome, proteins capable of forming amyloid-like fibrils , 2010, Proceedings of the National Academy of Sciences.
[51] Timothy A. Whitehead,et al. Computational Design of Proteins Targeting the Conserved Stem Region of Influenza Hemagglutinin , 2011, Science.